Insiders · LYRA

LYRA insider transactions

Lyra Therapeutics Inc. (LYRA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for LYRA

• 22d
  SEC Form 4 filed by Palasis Maria

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 22d
  SEC Form 4 filed by Cavalier Jason

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 107d
  Chief Financial Officer Cavalier Jason sold $2,587 worth of shares (769 units at $3.36), decreasing direct ownership by 0.15% to 518,547 units (SEC Form 4)

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 107d
  President & CEO Palasis Maria sold $5,726 worth of shares (1,702 units at $3.36), decreasing direct ownership by 0.15% to 1,096,733 units (SEC Form 4)

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 163d
  Large owner Perceptive Advisors Llc sold $182,515 worth of shares (45,875 units at $3.98) (SEC Form 4)

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 166d
  Large owner Perceptive Advisors Llc sold $344,219 worth of shares (70,390 units at $4.89) (SEC Form 4)

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 199d
  Amendment: SEC Form 4 filed by President & CEO Palasis Maria

  4/A - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 204d
  SEC Form 4 filed by President & CEO Palasis Maria

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 285d
  President & CEO Palasis Maria sold $13,944 worth of shares (1,565 units at $8.91), decreasing direct ownership by 0.14% to 1,098,435 units (SEC Form 4)

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 285d
  Chief Financial Officer Cavalier Jason sold $6,094 worth of shares (684 units at $8.91), decreasing direct ownership by 0.13% to 519,316 units (SEC Form 4)

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 344d
  SEC Form 4 filed by Director Snyderman Nancy Lynn Md

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 344d
  SEC Form 4 filed by Director Smith W Bradford

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 344d
  SEC Form 4 filed by Director Merrifield C Ann

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 344d
  SEC Form 4 filed by Director Tobin James R

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 470d
  President & CEO Palasis Maria was granted 800,000 shares, increasing direct ownership by 267% to 1,100,000 units (SEC Form 4)

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 470d
  Chief Financial Officer Cavalier Jason was granted 420,000 shares, increasing direct ownership by 420% to 520,000 units (SEC Form 4)

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 500d
  SEC Form 4 filed by President & CEO Palasis Maria

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 500d
  SEC Form 4 filed by Executive Chair Waksal Harlan

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 554d
  President & CEO Palasis Maria was granted 300,000 shares (SEC Form 4)

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 554d
  Chief Financial Officer Cavalier Jason was granted 100,000 shares (SEC Form 4)

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 680d
  SEC Form 4 filed by Director Tobin James R

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 680d
  SEC Form 4 filed by Director Smith W Bradford

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 680d
  SEC Form 4 filed by Director Snyderman Nancy Lynn Md

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 680d
  SEC Form 4 filed by Director Poukalov Konstantin

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 680d
  SEC Form 4 filed by Director Merrifield C Ann

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 680d
  SEC Form 4 filed by Director Altman Michael Seth

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 766d
  Waksal Harlan was granted 275,000 shares, increasing direct ownership by 105% to 536,966 units (SEC Form 4)

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 766d
  SEC Form 4 filed by Palasis Maria

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 814d
  SEC Form 4 filed by Bishop John E

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 814d
  SEC Form 4 filed by Nieman Richard

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 814d
  SEC Form 4 filed by Cavalier Jason

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 894d
  Waksal Harlan bought $74,095 worth of shares (25,000 units at $2.96), increasing direct ownership by 11% to 261,966 units (SEC Form 4)

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1018d
  SEC Form 4 filed by Palasis Maria (Amendment)

  4/A - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1025d
  SEC Form 4 filed by Tobin James R

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1025d
  SEC Form 4 filed by Smith W Bradford

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1025d
  SEC Form 4 filed by Poukalov Konstantin

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1025d
  SEC Form 4 filed by Merrifield C Ann

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1025d
  SEC Form 4 filed by Altman Michael Seth

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1025d
  SEC Form 4 filed by Snyderman Nancy Lynn Md

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1025d
  SEC Form 4 filed by Anderson Edward T

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1034d
  SEC Form 4 filed by Palasis Maria

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1058d
  SEC Form 4 filed by Nbvm Gp, Llc

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1058d
  SEC Form 4 filed by Anderson Edward T

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1058d
  SEC Form 4 filed by Perceptive Advisors Llc

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1152d
  SEC Form 4 filed by Bishop John E

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1152d
  SEC Form 3 filed by new insider Bishop John E

  3 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1178d
  SEC Form 4: Richard Robert E. was granted 30,000 shares

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1178d
  SEC Form 4 filed by Waksal Harlan

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1178d
  SEC Form 4: Noyes Corinne was granted 36,667 shares

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1178d
  SEC Form 4 filed by Cavalier Jason

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1178d
  SEC Form 4 filed by Palasis Maria

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1178d
  SEC Form 4 filed by Nieman Richard

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1383d
  SEC Form 4 filed by Nieman Richard

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1383d
  SEC Form 3 filed by new insider Nieman Richard

  3 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1404d
  SEC Form 4 filed by Altman Michael Seth

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1404d
  SEC Form 4 filed by Merrifield C Ann

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1404d
  SEC Form 4 filed by Smith W Bradford

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1404d
  SEC Form 4 filed by Poukalov Konstantin

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1404d
  SEC Form 4 filed by Anderson Edward T

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)
• 1404d
  SEC Form 4 filed by Waksal Harlan

  4 - Lyra Therapeutics, Inc. (0001327273) (Issuer)